Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) had Pre-Tax Income of $-1.77M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.77M |
|
-- |
|
-- |
|
$1.85M |
|
$-1.85M |
|
$0.08M |
|
|
Pre-Tax Income |
$-1.77M |
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
$-1.85M |
|
$-1.85M |
|
7.98M |
|
7.98M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$11.47M |
|
$0.17M |
|
$0.33M |
|
$11.81M |
|
$1.11M |
|
-- |
|
-- |
|
$1.11M |
|
$10.70M |
|
$10.70M |
|
$10.70M |
|
7.20M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.58% |
|
-16.58% |
|
-15.02% |
|
-16.58% |
|
$1.49 |
|
-- |
|
-- |
|